Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

314.49
Data as of Jul 10
 +3.56 / +1.14%
Today’s Change
227.64
Today|||52-Week Range
352.49
+14.26%
Year-to-Date
Benzinga's Top #PreMarket Gainers
Jul 10 / Benzinga
Regeneron Pharmaceuticals (REGN) Jumps: Stock Gains 7.4% - Tale of the Tape
Jul 02 / Zacks.com
Cramer: Valeant Is Hard to Stop
Jul 10 / TheStreet.com
Why 3D Systems, Arista Networks, and Regeneron Pharmaceuticals Jumped Today
Jul 01 / MotleyFool.com
Jim Cramer's Top Stock Picks: WMB AA BIIB REGN CELG GILD UNUM
Jul 10 / TheStreet.com
Amicus Up on Migalastat Study Update - Analyst Blog
Jul 01 / Zacks.com
Valeant Is Hard to Stop
Jul 10 / TheStreet.com
Allergan Slides as Migraine Drug Fails to Win Approval - Analyst Blog
Jul 01 / Zacks.com
Regeneron, Sanofi Drug Holds Up in Eczema Study
Jul 09 / MotleyFool.com
Synageva's Sebelipase Alfa Meets Primary Endpoint in ARISE - Analyst Blog
Jul 01 / Zacks.com
UPDATE: Regeneron, Sanofi Offer Positive Results from Phase 2b Study of Dupilum, All ...
Jul 09 / Benzinga
Regeneron boosted by Sanofi buying
Jul 01 / FT.com
5 Stocks Insiders Love Right Now
Jul 09 / TheStreet.com
Roche Launches cobas 6500 Testing System - Analyst Blog
Jul 01 / Zacks.com
Anacor's Kerydin Gets FDA Nod for Onychomycosis - Analyst Blog
Jul 09 / Zacks.com
Glaxo/Theravance Seek to Expand Breo Ellipta's Label - Analyst Blog
Jul 01 / Zacks.com
Biotech Stock Roundup: Regado Plunges on Study Update, Jazz Gains on Product Acquisit...
Jul 09 / Zacks.com
NPS Pharmaceuticals' Gattex Gets Updated Label - Analyst Blog
Jul 01 / Zacks.com
Is Opthotech Your Next Multibagger Stock?
Jul 08 / MotleyFool.com
AmerisourceBergen Acquires Minority Stake In Profarma - Analyst Blog
Jun 30 / Zacks.com
Growth and Dividends: Europe's Best Pharma Stock
Jul 07 / MotleyFool.com
Glaxo's Label Expansion Plans Marred as Arzerra Disappoints - Analyst Blog
Jun 30 / Zacks.com
Spectrum Pharmaceuticals Gains U.S. Approval of Beleodaq - Analyst Blog
Jul 07 / Zacks.com
Gilead Seeks Japanese Approval for Sovaldi - Analyst Blog
Jun 30 / Zacks.com
Glaxo/Theravance Drug Gets Japanese Approval - Analyst Blog
Jul 07 / Zacks.com
Roche's Avastin Receives Positive Opinion from CHMP - Analyst Blog
Jun 30 / Zacks.com
3 Stocks Reiterated As A Hold: TSLA, PM, REGN
Jul 07 / TheStreet.com
AbbVie's Oncology Candidate Progresses - Analyst Blog
Jun 30 / Zacks.com
RedHill Acquires Mesupron from Wilex - Analyst Blog
Jul 03 / Zacks.com
Bayer Drugs Get Positive CHMP Recommendation - Analyst Blog
Jun 30 / Zacks.com
Regeneron's $4.7 Billion Opportunity
Jul 03 / MotleyFool.com
MannKind's Afrezza Approval a Key Milestone - Analyst Blog
Jun 30 / Zacks.com
Insys Therapeutics' Epilepsy Therapy Gains FDA Orphan Drug Status - Analyst Blog
Jul 03 / Zacks.com
Eli Lilly & Boehringer's Insulin Copy Gets Positive EU Opinion - Analyst Blog
Jun 30 / Zacks.com
GlycoMimetics Up on FDA Agreement on Rivipansel Study - Analyst Blog
Jul 02 / Zacks.com
Vertex Pharmaceuticals' Kalydeco Wins Positive EU Opinion - Analyst Blog
Jun 30 / Zacks.com
Roche Acquires Seragon Pharma - Analyst Blog
Jul 02 / Zacks.com
CHMP Positive on Bristol-Myers/Pfizer's Eliquis for New Indication - Analyst Blog
Jun 30 / Zacks.com
Regeneron Shares Jump as Sanofi Increases Stake - Analyst Blog
Jul 02 / Zacks.com
BioDelivery Progresses with Clonidine Late-Stage Study - Analyst Blog
Jun 27 / Zacks.com
Biotech Stock Roundup: Vertex Jumps on Phase III Data, MannKind Scores FDA Approval -...
Jul 02 / Zacks.com
Coronado Falls on TSO Study Results - Analyst Blog
Jun 27 / Zacks.com
Stock Market News for July 02, 2014 - Market News
Jul 02 / Zacks.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.